Benitec BiopharmaBNTC
那斯達克 · USD
10.02
+0.43
(+4.48%)
收盤 09/29 03:56 (UTC+8)
09/29 03:56 (UTC+8)
Benitec BiopharmaBNTC
10.02
+0.43
(+4.48%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 14,430 | 13,582 | 13,377 | 9,803 | 9,834 | 7,993 | 8,610 | 5,791 | - | 4,141 |
研發費用 | 7,886 | 6,298 | 5,834 | 3,370 | 2,867 | 5,667 | 5,072 | 3,585 | 3,512 | 2,566 |
推銷及管理費用 | 6,544 | 7,284 | 7,543 | 6,433 | 6,967 | 2,326 | 3,538 | 2,206 | 2,036 | 1,578 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | -3 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -14,430 | -13,582 | -13,377 | -9,803 | -9,834 | -7,993 | -8,610 | -5,791 | -5,548 | -4,141 |
其他收入及費用 | 1,621 | 1,647 | 1,540 | 838 | -2,257 | -1,416 | -174 | 128 | -92 | -134 |
利息費用 | - | - | - | - | - | - | - | - | - | 16 |
稅前純益 | -12,809 | -11,935 | -11,837 | -8,965 | -8,805 | -7,159 | -7,357 | -5,059 | -4,720 | -4,279 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -12,809 | -11,935 | -11,837 | -8,965 | -8,805 | -7,159 | -7,357 | -5,059 | -4,720 | -4,279 |
基本每股稅後盈餘(元) | -0.26 | -0.24 | -0.26 | -0.22 | - | -0.38 | -0.26 | -0.18 | 0.41 | -0.23 |
稀釋每股稅後盈餘(元) | -0.26 | -0.24 | -0.26 | -0.22 | -0.21 | -0.39 | -0.27 | -0.18 | -0.11 | 4.54 |
基本平均股數(千股) | 49355.00 | 49386.00 | 45970.00 | 41521.00 | 73519.00 | 38599.00 | 37254.00 | 27883.00 | 8891.00 | 18281.00 |
稀釋平均股數(千股) | 49355.00 | 49386.00 | 45970.00 | 41521.00 | 73519.00 | 38599.00 | 37254.00 | 27883.00 | 8891.00 | 18281.00 |
還原基本每股稅後盈餘(元) | -0.26 | -0.24 | -0.26 | -0.22 | - | -0.38 | -0.26 | -0.18 | 0.41 | -0.23 |
還原稀釋每股稅後盈餘(元) | -0.26 | -0.24 | -0.26 | -0.22 | -0.21 | -0.39 | -0.27 | -0.18 | -0.11 | 4.54 |
還原基本平均股數(千股) | 49,355 | 49,386 | 45,970 | 41,521 | 73,519 | 38,599 | 37,254 | 27,883 | 8,891 | 18,281 |
還原稀釋平均股數(千股) | 49,355 | 49,386 | 45,970 | 41,521 | 73,519 | 38,599 | 37,254 | 27,883 | 8,891 | 18,281 |
EBITDA(千元) | -12,685 | -11,816 | -11,717 | -8,847 | -8,687 | -7,053 | -7,276 | -4,968 | -4,629 | -4,173 |